Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-02-22 @ 4:15 PM
Study NCT ID:
NCT03094195
Status:
TERMINATED
Last Update Posted:
2021-10-08
First Post:
2017-03-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Post-herpetic Neuralgia | View |